Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Gower Publishing

- PMLiVE

Loxo’s cancer drug pair attracts $1.5bn deal with Bayer

The German pharma group will gain full rights to the drugs outside the US

- PMLiVE

Shire wins CHMP backing for Adynovi

Haemophilia A treatment backed for European approval

- PMLiVE

Ann Barbier joins Translate Bio as its chief medical officer

She will take responsibility for leading the US biotech's clinical R&D

Orion appoints VP of oncology, R&D

Professor Heikki Joensuu joins from Helsinki University Hospital

- PMLiVE

Adding value in emerging markets

What benefit do branded generics bring to patients around the world?

- PMLiVE

A new picture

Changing the route to brand growth

- PMLiVE

Another well-deserved promotion at Porterhouse Medical

We are delighted to announce the promotion of one of our scientific staff, Emma, to the role of senior medical writer. Not only was Emma the winner of our 2016 Entrepreneur...

Porterhouse Medical Group

- PMLiVE

First digital medicine approved in the US

The antipsychotic drug has a built-in digital tracking sensor

- PMLiVE

Boehringer claims EU okay for Humira biosimilar

But won’t launch before expiration of the respective SPC for adalimumab in October 2018

- PMLiVE

Fujifilm expands biopharma development and manufacturing business

Company invests 3.2bn yen in US and UK sites

- PMLiVE

Zelluna appoints Miguel Forte as CEO

He joins the Norwegian biotech from Bone Therapeutics

- PMLiVE

Storm Therapeutics strengthens its board

Professor Paul Workman joins as an independent director

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links